HIMS — Recent News Coverage
All news mentioning HIMS in ESEN's AI-graded feed
News stories with HIMS as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on HIMS. See /coverage/HIMS for the 30-day aggregate.
FINANCE.YAHOO.COM
·
2026-08-14
HIGH
BEARISH
CORR0.42
Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset?
$HIMS
◈ ESEN AI
HIMS delivered robust top-line expansion with 38% revenue growth and a 19% subscriber base increase, signaling sustained demand in the telehealth sector. However, margin compression driven by GLP-1 drug pricing pressure…
SEEKINGALPHA.COM
·
2026-08-14
NEUTRAL
BULLISH
CORR0.58
Hims & Hers Health's Next Act: Making Its Own Drugs Again (NYSE:HIMS)
$HIMS
◈ ESEN AI
HIMS reported 2Q revenue growth of 38% year-over-year and raised full-year guidance, signaling strong operational momentum in the telehealth and direct-to-consumer pharmacy space. The company's execution on scale demons…
FINANCE.YAHOO.COM
·
2026-08-11
NEUTRAL
NEUTRAL
CORR0.42
Hims & Hers Q2 revenue beat offset by wider-than-expected loss
$HIMS
◈ ESEN AI
Hims & Hers reported a classic earnings dichotomy: top-line acceleration against bottom-line deterioration. Revenue growth beat consensus, signaling market demand momentum in telehealth and weight-loss pharmaceuticals. …
SEEKINGALPHA.COM
·
2026-08-11
LOW
NEUTRAL
CORR0.55
Hims & Hers Health, Inc. (HIMS) Q2 2026 Earnings Call Transcript
$HIMS
◈ ESEN AI
HIMS released its Q2 2026 earnings call transcript on August 10, 2026. This represents a scheduled disclosure of management commentary and financial results already reported to the market, providing investors with detai…
SEEKINGALPHA.COM
·
2026-08-11
LOW
NEUTRAL
CORR0.42
Hims & Hers Health, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:HIMS) 2026-08-11
$HIMS
◈ ESEN AI
HIMS published its Q2 2026 earnings call presentation deck on August 11, 2026, a routine procedural disclosure accompanying quarterly results announcement. This is a scheduled financial reporting event and does not cons…
SEEKINGALPHA.COM
·
2026-07-31
NEUTRAL
BULLISH
CORR0.52
Hims & Hers Health: Still An Undervalued Company With Tremendous Upside (NYSE:HIMS)
$HIMS
◈ ESEN AI
HIMS has appreciated significantly year-to-date, but this analyst assessment argues the stock remains undervalued relative to long-term growth drivers. The company's exposure to GLP-1 medication distribution—a high-grow…
SEEKINGALPHA.COM
·
2026-07-30
NEUTRAL
BULLISH
CORR0.45
Hims & Hers Health Stock: FTC Panic Gift (NYSE:HIMS)
$HIMS
◈ ESEN AI
HIMS faces regulatory headwinds via FTC lawsuit, which typically triggers investor panic in healthcare equities. However, the article positions this as a buying opportunity by anchoring to prior telehealth settlement pr…
CNBC
·
2026-07-29
HIGH
BEARISH
CORR-0.72
Hims and Hers shares fall 10% as FTC sues company over data, billing practices
$HIMS
◈ ESEN AI
The FTC's enforcement action against HIMS represents a material regulatory headwind for the telehealth sector, specifically targeting data governance and consumer protection practices. The lawsuit alleges unauthorized s…
ZACKS.COM
·
2026-07-28
LOW
BEARISH
CORR0.15
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note
$HIMS
◈ ESEN AI
HIMS declined 3.04% in the most recent session, closing at $29.32, demonstrating divergence from broader market strength. This underperformance suggests sector-specific or company-level headwinds decoupled from macro ta…
ZACKS.COM
·
2026-07-14
LOW
NEUTRAL
CORR0.42
Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know
$HIMS
◈ ESEN AI
HIMS closed at $35.15, posting a modest intraday gain of 2.24% in the most recent session. This incremental price movement reflects routine daily volatility rather than a material catalyst or shift in market sentiment. …
SEEKINGALPHA.COM
·
2026-07-08
NEUTRAL
BULLISH
CORR0.42
Hims & Hers Health Stock: The Market Still Doesn't Get It (NYSE:HIMS)
$HIMS
◈ ESEN AI
HIMS is expanding its international footprint and diversifying its healthcare service offerings beyond its high-profile longevity therapy segment. The thesis centers on market underestimation of the company's platform b…
ETFTRENDS.COM
·
2026-07-02
NEUTRAL
BULLISH
CORR0.58
Amplify Online Retail ETF Rides a Summer Surge in Performance
$IBUY
$W
$HIMS
◈ ESEN AI
The Amplify Online Retail ETF (IBUY) demonstrated notable strength during June 2026, reflecting a seasonal uptick in e-commerce activity and renewed investor appetite for digitally-native retail exposure. Performance dr…
FINANCE.YAHOO.COM
·
2026-06-24
NEUTRAL
BULLISH
CORR0.52
Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays’ Target Increase?
$HIMS
◈ ESEN AI
Barclays elevated its price target on HIMS by 34% to $39.00, maintaining an Overweight stance. This represents analyst confidence in the company's positioning within the expanding weight loss pharmaceutical market, wher…
ZACKS.COM
·
2026-06-19
LOW
NEUTRAL
CORR0.35
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
$HIMS
◈ ESEN AI
HIMS is registering elevated retail interest on the Zacks platform, suggesting heightened investor attention but without a clear directional catalyst. The article provides minimal substantive information about fundament…
SEEKINGALPHA.COM
·
2026-06-16
NEUTRAL
BULLISH
CORR0.45
Hims & Hers Enters A New Phase (NYSE:HIMS)
$HIMS
◈ ESEN AI
Hims & Hers (HIMS) has articulated multi-year financial targets that signal management confidence in the telehealth and digital health platform's scaling trajectory. The 2030 guidance of $6.5B in revenue and $1.3B in ad…
INSIDERMONKEY.COM
·
2026-06-15
NEUTRAL
BULLISH
CORR0.72
10 Stocks Stealing the Spotlight from Wall Street Giants
$TWST
$NVDA
$HIMS
$RXRX
◈ ESEN AI
A collection of smaller-cap equities demonstrated strength on Monday, with D-Wave Quantum leading gains at 12.37 percent, signaling renewed appetite for growth-oriented securities outside the megacap cohort. This rotati…
FINANCE.YAHOO.COM
·
2026-06-11
HIGH
BEARISH
CORR-0.72
The GLP-1 stock nobody is pricing in isn’t a drugmaker
$MCD
$YUM
$QSR
$SBUX
$HIMS
◈ ESEN AI
The analysis highlights a structural demand shock emerging from widespread GLP-1 adoption, affecting consumer discretionary spending on fast food. With approximately 30 million Americans—roughly 1 in 8 adults—currently …
EXPLORE OTHER FILTERS